News

October 16, 2019

Ketamine: From Street Drug to Powerful Anti-Depressant

Dr. Rahul Khare, founder and CEO of Innovative Ketamine, was recently interviewed for an article about ketamine that examined how the psychedelic street drug, known as Special K, has become a mood-balancing powerhouse that has the potential to tackle the mental health crisis in the United States. Unfortunately, you may have missed it if you didn’t pick up the latest issue of Playboy. In the article, Khare, who has been an emergency medicine physician for nearly 20 years, explained that […]
October 9, 2019
ketamine treatment

A Cloud of Anxiety Lifted: Lauren’s story

  At 34 years-old, Lauren wondered if her life would ever change. She suffered from severe depression, anxiety, chronic PTSD, and had been suicidal since age 14. Lauren has a passion for seeing the world and has traveled to 67 countries. Unfortunately, she’s also seen the inside of too many foreign emergency rooms thanks to uncontrolled anxiety and panic attacks. Scared and frustrated, Lauren pursued Ketamine infusions as a last resort, hoping the constant cloud of anxiety that shadowed her […]
September 18, 2019

Ketamine Emerges as a Game-Changer for the Treatment of Mood Disorders

Patients grappling with long-term depression deserve alternatives to benzodiazepine drugs which often only temporarily address their symptoms. Innovative Ketamine was among the first clinics in Chicago to offer ketamine infusions, a treatment that is so effective, many believe it has the potential to help curb the suicide rate in our country. Ketamine is an anesthetic that has been used in emergency and surgical settings since the 1960s. It is the first breakthrough in the treatment of depression in decades, and […]
August 14, 2019

WGNTV: Ketamine Therapy in Chicago at Innovative Ketamine

  Ketamine therapy has increased in popularity for treating depression, PTSD, fibromyalgia and other conditions. Dr. Rahul Khare, MD explains how ketamine treatment is administered. Read More >>
June 23, 2019
Techie Ketamine

Techies Are Using Ketamine to Fight Their Depression

  Sean Spencer is a pretty successful entrepreneur in LA’s startup community but he also struggles with depression, so he uses ketamine to help with his lows.   Read More >>
June 10, 2019
Ketamine Testimonial

Leslie’s Testimonial

  Meet Leslie, a patient of Innovative Ketamine who has seen first-hand how ketamine has given her her life back.   Interested in learning more about ketamine?   Book Now
May 24, 2019
ABC7 Ketamine

ABC7 Chicago I-Team: ‘Revolutionary’ depression treatment brings hope to patients amid concerns about oversight

 ABC7 Chicago: Ketamine has been hailed as a breakthrough treatment for depression and other disorders. The drug was also in the spotlight this week as medics revealed its key role in the harrowing rescue of a Thai soccer team trapped in a cave last year. But ketamine’s history as an illicit, trippy party drug has some concerned about potential abuse. The Food and Drug Administration recently approved one version of this treatment while a rapidly growing cottage industry of […]
April 18, 2019

Innovative Ketamine News: Esketamine (Spravato) Approved by the FDA

As many of you have heard, there is a new treatment for depression: Esketamine (aka Spravato). Recently, Johnson & Johnson, a pharmaceutical company, has manufactured a new medication called Spravato or Esketamine. Esketamine is an isomer or mirror image copy of ketamine. This is a close chemical relation to ketamine, an anesthetic which has been used for 50 years. Johnson & Johnson has received FDA approval, which specifically states that the drug will only be available in certified clinics where doctors […]
April 18, 2019
ketamine treatment

Hopes and hype for ketamine to treat depression – USA Today

Some studies show ketamine treatment can provide relief within hours for tough-to-treat depression and suicidal behavior and clinics promising unproven benefits have popped up nationwide. But more research is needed to know long-term benefits and risks. (Oct. 31) Read More >>